Clinical trial Recruiting at 1 site Interventional Ages 50 to 64

Reducing blood pressure in mid-life adults who binge drink

Official title: Reducing Blood Pressure in Mid-life Adult Binge Drinkers: the Role of Microvascular Function and Sympathetic Activity

Run by The University of Texas at Arlington · NCT05522075 · Data updated 2026-11-12

This study is testing whether an 8-week exercise program can help mid-life adults who binge drink lower their blood pressure and improve their overall health.

More Aging trials

Quick facts

Study typeInterventional
Ages50 Years to 64 Years
SexAll
Enrollment55 (estimated)
SponsorThe University of Texas at Arlington
Academic / other
Locations1 site (Arlington, Texas)
StatusRecruiting
StartedNovember 21, 2022
Main results expectedDecember 31, 2026
Study endsApril 30, 2027
Registry record updatedJune 1, 2026
Trial IDNCT05522075 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are men and women aged 50-64 who binge drink, abstain from alcohol, or drink moderately.

Probably not a fit

Patients with a history of cardiovascular disease, diabetes, or other significant health issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the relationship between blood pressure, microvascular function, and sympathetic nerve activity in mid-life adult binge drinkers compared to alcohol abstainers and moderate drinkers. In the first phase, baseline assessments will be conducted to gather data on these parameters. The second phase involves an 8-week aerobic exercise training program specifically for binge drinkers, with follow-up measurements to evaluate the impact of the intervention on their health metrics.

Why it matters

Potential benefit: If successful, this study could lead to effective interventions for reducing blood pressure and improving cardiovascular health in mid-life binge drinkers.

How similar studies have gone: While there have been studies on exercise and alcohol consumption, this specific approach targeting mid-life binge drinkers is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men and women (50-64 years of age) who do not drink alcohol, who drink at moderate levels, or who binge drink
* Female subjects will be postmenopausal (i.e., cessation of menses for ≥1 yr).
* Subjects who can speak and understand English.

Exclusion Criteria:

* a history of diabetes, cardiovascular disease, liver, or renal disease
* current or history of smoking and illicit drug use
* blood pressure ≥160/100 mm Hg
* other known traditional cardiovascular disease risks: obesity (BMI≥35 kg/m2), or hyperlipidemia (total cholesterol\>230 mg/dl and/or LDL cholesterol\>160 mg/dl)
* active infection (in the past 2 months)
* a history of seizures, cancer, or inflammatory disease (i.e., gout or rheumatoid)
* unstable body weight (\>5% change during the past 6 months)
* regular aerobic exercise training (i.e., they engage in 30 min of structured aerobic exercise at least 3 times per week)
* current use of hormone replacement therapy (i.e., estrogen, progesterone, and testosterone)

Where it's running

  • University of Texas at Arlington
    Arlington, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Chueh-Lung Hwang, PhD — University of Texas at Arlington
  • Study coordinator: Chueh-Lung Hwang, PhD
  • Email: chuehlung.hwang@uta.edu
  • Phone: 8172729722

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.